Optimizing the Influenza Clinical Decision Support Tool
1 other identifier
interventional
25,881
1 country
1
Brief Summary
The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 26, 2017
CompletedStudy Start
First participant enrolled
January 16, 2018
CompletedFirst Posted
Study publicly available on registry
January 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 21, 2023
CompletedApril 1, 2024
March 1, 2024
5.7 years
December 26, 2017
March 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Alert Cancelation Rate
Number of times alert fires in medical record within 2 Month period
2 months.
Secondary Outcomes (1)
Vaccination Rate at Discharge
2 months
Study Arms (2)
Usual Care
ACTIVE COMPARATORThe current version of the alert will fire for this arm of the study.
Alert Iteration
ACTIVE COMPARATORA modified version of the alert will fire for this arm of the study.
Interventions
Intervention includes the current version of the Influenza Alert that fires in the electronic medical record if the patient has not received the flu vaccination, as part of usual care.
Intervention includes various iterations of the Influenza Alert that fires in the electronic medical record if the patient has not received the flu vaccination.
Eligibility Criteria
You may qualify if:
- All NYU Langone Health inpatients eligible for the Influenza clinical decision support tool
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
Related Publications (1)
Austrian J, Mendoza F, Szerencsy A, Fenelon L, Horwitz LI, Jones S, Kuznetsova M, Mann DM. Applying A/B Testing to Clinical Decision Support: Rapid Randomized Controlled Trials. J Med Internet Res. 2021 Apr 9;23(4):e16651. doi: 10.2196/16651.
PMID: 33835035DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Leora Horwitz, MD, MHS
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 26, 2017
First Posted
January 30, 2018
Study Start
January 16, 2018
Primary Completion
October 7, 2023
Study Completion
November 21, 2023
Last Updated
April 1, 2024
Record last verified: 2024-03